Synovis Life Technologies to Present at Oppenheimer 20th Annual Healthcare Conference November 3

Live Webcast at 3:30 p.m. CT (4:30 p.m. ET)

• Press Release
• Source: Synovis Life Technologies, Inc.
• On 12:28 pm EDT, Thursday October 29, 2009

ST. PAUL, Minn.--(BUSINESS WIRE)--Synovis Life Technologies, Inc. (Nasdaq: SYNO - News), a leading biomaterial and surgical products company, will present at the Oppenheimer 20^th Annual Healthcare Conference at 3:30 p.m. CT (4:30 p.m. ET) on Tuesday, Nov. 3, 2009, at the Waldorf Astoria Hotel in New York City. Richard W. Kramp, president and chief executive officer, and Brett A. Reynolds, chief financial officer, will discuss the company’s recent performance and market opportunities.

Related Quotes

Symbol	Price	Change
SYNO	12.08	-0.22

{"s" : "syno","k" : "c10,l10,p20,t10","o" : "","j" : ""}

To access the webcast, go to the investors’ section of the Synovis Web site, www.synovislife.com, and click on the webcast icon. The archived webcast will be available at 5:30 p.m. CT on Tuesday, Nov. 3.

About Synovis Life Technologies
Synovis Life Technologies, Inc., based in St. Paul, Minn., develops, manufactures and markets mechanical and biological products used by several surgical specialties for the repair of soft tissue damaged or destroyed by disease or injury. The company’s products are designed to reduce risks and/or facilitate critical surgeries, improve patient outcomes and reduce healthcare costs. For additional information on Synovis Life Technologies and its products, visit the company’s Web site at www.synovislife.com.

Padilla Speer Beardsley Inc.
Nancy A. Johnson, 612-455-1745
or
Marian Briggs, 612-455-1742
or
Synovis Life Technologies, Inc.
Richard Kramp, 651-796-7300
President and CEO
or
Brett Reynolds, 651-796-7300
CFO